The €60 million ($63 million) Shanbally, Cork expansion aims to increase production capacity. The facility will manufacture bulk drug substances and drug products and perform fill-finish services. The ...

Biotechnology company Amgen is building a $1 billion drug substance manufacturing facility in Holly Springs, North Carolina, expanding its presence in the region with its second such facility. In ...

Indian pharmaceutical company Intas Pharmaceuticals signed a deal to acquire Udenyca, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications. Accord ...